Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(80.0%)
Phase 1
1(20.0%)
5Total
N/A(4)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT00581373Not ApplicableActive Not Recruiting

Water and the Gastropressor Response - Diurnal Variability

Role: lead

NCT00580996Not ApplicableActive Not Recruiting

Water and the Gastropressor Response - Tachyphylaxis

Role: lead

NCT00692471Active Not Recruiting

Sleep Actigraphy in Postural Tachycardia Syndrome (POTS)

Role: lead

NCT00608725Not ApplicableActive Not Recruiting

Pathophysiology of Orthostatic Intolerance

Role: lead

NCT00581321Not ApplicableActive Not Recruiting

Oral Water Ingestion in Heart Transplant Patients

Role: lead

NCT00262470Phase 1Active Not Recruiting

Treatment of Orthostatic Intolerance

Role: lead

NCT00581022Completed

Objective Sleep Disturbances in Orthostatic Intolerance

Role: lead

All 7 trials loaded